TIGAN INJECTION Rx
Generic Name and Formulations:
Trimethobenzamide HCl 100mg/mL; for IM inj.
Par Pharmaceutical, Inc.
Indications for TIGAN INJECTION:
Treatment of post-op or gastroenteritis-associated nausea and vomiting.
Use lowest effective dose. 200mg IM 3–4 times daily.
Acute dystonic reactions. Extrapyramidal symptoms. May mask other serious disorders (eg, encephalopathy, metabolic imbalance). Children (Reye's syndrome). Monitor for hepatic impairment; discontinue if occurs. Renal impairment. Elderly. Pregnancy. Nursing mothers.
Potentiated by alcohol (avoid), other CNS depressants (eg, sedatives, hypnotics, opiates, anxiolytics, antipsychotics, anticholinergics); monitor.
Parkinson-like symptoms, drowsiness, blood dyscrasias, blurred vision, coma, seizures, depression, diarrhea, disorientation, dizziness, jaundice, hypotension (inj), headache, muscle cramps, opisthotonos; hepatotoxicity, hypersensitivity reactions.
Caps—100; Single-use vials (2mL)—25; Multi-dose vial (20mL)—1
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL